Literature DB >> 8838732

Effects of knee flexion angle at graft fixation on the outcome of anterior cruciate ligament reconstruction.

S Asahina1, T Muneta, T Ishibashi, H Yamamoto.   

Abstract

Clinical outcome in 44 patients who underwent anterior cruciate ligament (ACL) reconstruction with hamstring tendons augmented by the ligament augmentation device for chronic ACL deficiency was studied; average follow-up was 38 months (range, 24 to 52 months). In 19 patients, grafts were fixed with the knees at full extension (group 1), whereas in 25 patients, the grafts were fixed with the knees at 30 degrees of flexion (group 2). The results of subjective testing (Lysholm score), the Lachman test, the pivot-shift test, muscle strength testing, angle of extension loss, and follow-up arthroscopy were compared to assess the effects of flexion angle at fixation on stability and function. The range of motion in group 1 was significantly better than that in group 2. The stability of the knees and the arthroscopic appearance of the grafts in group 1 were, however, significantly worse than those in Group 2.

Entities:  

Mesh:

Year:  1996        PMID: 8838732     DOI: 10.1016/s0749-8063(96)90222-4

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  3 in total

Review 1.  Anterior cruciate ligament reconstruction and the long-term incidence of gonarthrosis.

Authors:  J Gillquist; K Messner
Journal:  Sports Med       Date:  1999-03       Impact factor: 11.136

2.  Biomechanics and anterior cruciate ligament reconstruction.

Authors:  Savio L-Y Woo; Changfu Wu; Ozgur Dede; Fabio Vercillo; Sabrina Noorani
Journal:  J Orthop Surg Res       Date:  2006-09-25       Impact factor: 2.359

3.  Comparison of bioabsorbable suture anchor fixation on the tibial side for anterior cruciate ligament reconstruction using free soft tissue graft: experimental laboratory study on porcine bone.

Authors:  Myung Ku Kim; Suk In Na; Jong Min Lee; Ju Yong Park
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.